Article Information
History
- December 21, 2021.
Article Versions
- Version 1 (December 2, 2021 - 08:40).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Thomas Lechmere1,#,
- Luke B. Snell2,#,
- Carl Graham1,
- Jeffrey Seow1,
- Zayed A. Shalim1,
- Themoula Charalampous2,
- Adela Alcolea-Medina2,
- Rahul Batra2,
- Gaia Nebbia2,
- Jonathan D. Edgeworth2,
- Michael H. Malim1 and
- Katie J. Doores1,*
- 1Department of Infectious Diseases, School of Immunology & Microbial Sciences, King’s College London, London, UK
- 2Centre for Clinical Infection and Diagnostics Research, Department of Infectious Diseases, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
- ↵*To whom correspondence should be addressed: katie.doores{at}kcl.ac.uk
↵# These authors contributed equally
Posted December 21, 2021.
Broad neutralization of SARS-CoV-2 variants, including omicron, following breakthrough infection with delta in COVID-19 vaccinated individuals
